Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Mar 16, 2024; 16(3): 102-107
Published online Mar 16, 2024. doi: 10.4253/wjge.v16.i3.102
Precision in detecting colon lesions: A key to effective screening policy but will it improve overall outcomes?
Luis Ramon Rabago, Maria Delgado Galan
Luis Ramon Rabago, Department of Gastroenterology, Hospital San Rafael, Madrid 28016, Spain
Maria Delgado Galan, Gastroenterology Department, Hospital Severo Ochoa, Leganes 28914, Spain
Author contributions: Both authors have revised the issue, bibliography, and made editorial contributions to the manuscript.
Conflict-of-interest statement: We do not have any conflict-of-interest at all.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Luis Ramon Rabago, Doctor, PhD, Chief, Former Contract Professor, Medical Assistant, Staff Physician, Department of Gastroenterology, Hospital San Rafael, Street Serrano 199, Madrid 28016, Spain. lrabagot@gmail.com
Received: December 15, 2023
Peer-review started: December 15, 2023
First decision: December 23, 2023
Revised: December 29, 2023
Accepted: January 23, 2024
Article in press: January 23, 2024
Published online: March 16, 2024
Core Tip

Core Tip: The endoscope's texture and color enhancement imaging mode, combined with chromoendoscopy, has demonstrated improvements in the characterization of mucosal colonic lesions, providing better visualization of their borders and lesion surfaces. However, its real impact on lesion recurrence and rates of interval cancers is yet to be proven through more prospective studies.